Rituximab as a single agent in the management of adult patients with haemophilia A and inhibitors: marked reduction in inhibitor level and clinical improvement in bleeding but failure to eradicate the inhibitor. [electronic resource]
Producer: 20090804Description: 210-6 p. digitalISSN:- 1365-2516
- Adult
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Murine-Derived
- Factor VIII -- immunology
- Hemophilia A -- complications
- Hemorrhage -- prevention & control
- Humans
- Immune Tolerance -- drug effects
- Immunologic Factors -- therapeutic use
- Isoantibodies -- blood
- Male
- Rituximab
- Young Adult
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.